Corrigendum: Sialyllactose and Galactooligosaccharides Promote Epithelial Barrier Functioning and Distinctly Modulate Microbiota Composition and Short Chain Fatty Acid Production In Vitro
- 1Cell Biology and Immunology Group, Wageningen University & Research, Wageningen, Netherlands
- 2Host-Microbe Interactomics Group, Wageningen University & Research, Wageningen, Netherlands
- 3Microbiology and Systems Biology, The Netherlands Organization for Applied Scientific Research, Zeist, Netherlands
- 4FrieslandCampina, Amersfoort, Netherlands
by Perdijk, O., van Baarlen, P., Fernandez-Gutierrez, M. M., van den Brink, E., Schuren, F. H. J., Brugman, S., et al. (2019). Front. Immunol. 10:94. doi: 10.3389/fimmu.2019.00094
Figure 3. SL and GOS differentially modulate microbiota composition. Batch cultures of adult and infant pooled fecal samples cultured in growth medium were supplemented with or without SL or GOS in duplo. Fecal samples were collected at the start of the batch culture and after 3, 6, 9, and 24 h. Microbiota composition on genus level (A–F) and on species level (G,H) was determined by qPCR and chip analysis, respectively. Bacterial numbers were shown as mean ± SEM of two independent batch cultures. Raw fluorescence data are shown for both individual runs for chip analysis.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: epithelium, galactooligosaccharides, microbiota, short chain fatty acids, sialyllactose
Citation: Perdijk O, van Baarlen P, Fernandez-Gutierrez MM, van den Brink E, Schuren FHJ, Brugman S, Savelkoul HFJ, Kleerebezem M and van Neerven RJJ (2019) Corrigendum: Sialyllactose and Galactooligosaccharides Promote Epithelial Barrier Functioning and Distinctly Modulate Microbiota Composition and Short Chain Fatty Acid Production In Vitro. Front. Immunol. 10:762. doi: 10.3389/fimmu.2019.00762
Received: 20 March 2019; Accepted: 21 March 2019;
Published: 10 April 2019.
Approved by:Frontiers in Immunology Editorial Office, Frontiers Media SA, Switzerland
Copyright © 2019 Perdijk, van Baarlen, Fernandez-Gutierrez, van den Brink, Schuren, Brugman, Savelkoul, Kleerebezem and van Neerven. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: R. J. Joost van Neerven, email@example.com